Genetic Variants and Interactions from a Pharmacist-Led Pharmacogenomics Service for Pace
- 1 July 2019
- journal article
- research article
- Published by Taylor & Francis in Pharmacogenomics
- Vol. 20 (10) , 709-718
Abstract
Aim: Evaluate results of pharmacogenomics testing for participants enrolled in the Program of All-inclusive Care for the Elderly (PACE). Materials & methods: A convenience sample of 100 participants from the PHARM-GENOME-PACE study. Genetic variants were determined by pharmacogenomics testing. Drug-gene interactions (DGIs), drug-drug-gene interactions (DDGIs) and phenoconversions were interrogated from a clinical decision support system. Results: In total, 146 genetic variants, 169 DGIs and 125 DDGIs were detected. DGIs and DDGIs occurred most commonly with the CYP2D6 gene (36.1 and 39.2%, respectively). There were 280 instances of phenoconversions; majority (62.9%) affecting the CYP3A4 isoenzyme. Conclusion: Prevalence of exposures to DGIs and DDGIs among PACE participants is high. Pharmacists using a clinical decision support system can support PACE practitioners with assessing multidrug simultaneous interactions. Clinical trial registration: NCT03257605.Keywords
Funding Information
- Tabula Rasa HealthCare
- CareKinesis (NCT03257605)
This publication has 32 references indexed in Scilit:
- The importance of monitoring adverse drug reactions in elderly patients: the results of a long-term pharmacovigilance programmeExpert Opinion on Drug Safety, 2016
- Cytochrome P–450 gene and drug interaction analysis in patients referred for pharmacogenetic testingAmerican Journal of Health-System Pharmacy, 2016
- Understanding and preventing drug–drug and drug–gene interactionsExpert Review of Clinical Pharmacology, 2014
- How Common are Drug and Gene Interactions? Prevalence in a Sample of 1143 Patients with CYP2C9 , CYP2C19 and CYP2D6 GenotypingPharmacogenomics, 2014
- Prevalence and Risk of Potential Cytochrome P450–Mediated Drug-Drug Interactions in Older Hospitalized Patients with PolypharmacyAnnals of Pharmacotherapy, 2013
- Incidence and Predictors of Adverse Drug Reactions Caused by Drug-Drug Interactions in Elderly Outpatients: A Prospective Cohort StudyJournal of Pharmacy & Pharmaceutical Sciences, 2012
- Potentially Harmful Drug–Drug Interactions in the Elderly: A ReviewThe American Journal of Geriatric Pharmacotherapy, 2011
- Detection and Prevention of Drug–Drug Interactions in the Hospitalized Elderly: Utility of New Cytochrome P450–Based SoftwareThe American Journal of Geriatric Pharmacotherapy, 2011
- Epidemiology and characteristics of adverse drug reactions caused by drug–drug interactionsExpert Opinion on Drug Safety, 2011
- Drug-Drug Interactions Among Elderly Patients Hospitalized for Drug ToxicityJAMA, 2003